A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone® 3.75 mg in healthy male subjects

• Asıl Yazarlar: Xingjiang Hu (Yazar), Qiao Zhang (Yazar), Yunliang Zheng (Yazar), You Zhai (Yazar), Nana Xu (Yazar), Qingwei Zhao (Yazar), Jian Liu (Yazar), Longyan Wan (Yazar), Jindan Luo (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Leuprolide acetate microspheres developed by Shanghai Livzon Pharmaceutical Co., Ltd. (T) have been marketed in China for more than 10 years, benefiting a large number of patients, and will continue to play an important role in China. However, as a generic drug, it is unclear whether there is a diff...